PREDICTIVE VALUE OF MGMT PROMOTER METHYLATION QUANTITATIVE ASSESSMENT IN GLIOBLASTOMA, WHICH OPTIMAL CUT-POINT?

被引：0
|
作者：
de Saint-Denis, T. [1 ]
Lerhun, E. [1 ]
Ramirez, C. [1 ]
Devos, P. [2 ]
Maurage, C. A. [3 ]
Dubois, F. [1 ]
Reyns, N. [1 ]
Escande, F. [4 ]
机构：
[1] CHRU Lille, F-59037 Lille, France
[2] CHRU Lille, Dept Biostat, F-59037 Lille, France
[3] CHRU Lille, Serv Anat Pathol, F-59037 Lille, France
[4] CHRU Lille, Ctr Biol & Patol, F-59037 Lille, France
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P04.10
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic value of methylation status of MGMT gene promoter in patients with glioblastoma after combination treatment.
    Vlasov, Stanislav G.
    Gvaldin, Dmitry Yu.
    Pushkin, Anton A.
    Kit, Oleg I.
    Engibaryan, Marina A.
    Sakun, Pavel G.
    Voshedskiy, Vitaliy I.
    Gusareva, Marina A.
    Komandirov, Maksim A.
    Kultysheva, Yulia A.
    Solntseva, Anna A.
    Rodionova, Olga G.
    Karnaukhova, Elena A.
    Khatyushin, Vladislav E.
    Teplyakova, Maria A.
    Kecheryukova, Takhmina M.
    Zbrailova, Ekaterina S.
    Rogova, Tatiana S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] Incremental Prognostic Value of ADC Histogram Analysis over MGMT Promoter Methylation Status in Patients with Glioblastoma
    Choi, Yoon Seong
    Ahn, Sung Soo
    Kim, Dong Wook
    Chang, Jong Hee
    Kang, Seok-Gu
    Kim, Eui Hyun
    Kim, Se Hoon
    Rim, Tyler Hyungtaek
    Lee, Seung-Koo
    [J]. RADIOLOGY, 2016, 281 (01) : 175 - 184
  • [43] The combined EGFR protein expression analysis refines the prognostic value of the MGMT promoter methylation status in glioblastoma
    Tini, Paolo
    Pastina, Pierpaolo
    Nardone, Valerio
    Sebaste, Lucio
    Toscano, Marzia
    Miracco, Clelia
    Cerase, Alfonso
    Pirtoli, Luigi
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 149 : 15 - 21
  • [44] PREDICTIVE VALUE OF MGMT PROMOTER (PMGMT) METHYLATION STATUS ON PSEUDOPROGRESSION (PSP) AND SURVIVAL ANALYSIS IN GLIOBLASTOMA (GBM) PATIENTS: A RETROSPECTIVE SINGLE INSTITUTIONAL ANALYSIS
    Interno, V.
    De Santis, P.
    Stucci, L.
    Porta, C.
    [J]. NEURO-ONCOLOGY, 2021, 23 : 54 - 54
  • [45] QUANTITATIVE ANALYSIS OF MGMT PROMOTER METHYLATION AND ITS PROGNOSTIC VALUE IN GLIOBLASTOMA MULTIFORME (GBM) PATIENTS TREATED WITH ALKYLATING CHEMOTHERAPY-PRELIMINARY REPORT
    Bajwa, Samarjeet
    Flanagan, Lisa
    Hernandez, Stephania
    Fu, Dan Beverly
    Bota, Daniela
    Kong, Xiao-Tang
    [J]. NEURO-ONCOLOGY, 2018, 20 : 159 - 159
  • [46] Concordance and clinical value of the MGMT promoter methylation pattern in tissue with paired serum and MGMT protein expression in a series of glioblastoma (GB) patients
    Balana, C.
    Carrato, C.
    Ramirez, J.
    Berdiel, M.
    Kaen, D.
    Sanchez, J.
    Taron, M.
    Hostalot, C.
    Ariza, A.
    Rosell, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients
    Cheng, Wen
    Ren, Xiufang
    Cai, Jinquan
    Zhang, Chuanbao
    Li, Mingyang
    Wang, Kuanyu
    Liu, Yang
    Han, Sheng
    Wu, Anhua
    [J]. ONCOTARGET, 2015, 6 (30) : 29285 - 29295
  • [48] HDAC4, a prognostic and chromosomal instability marker, refines the predictive value of MGMT promoter methylation
    Wen Cheng
    Mingyang Li
    Jinquan Cai
    Kuanyu Wang
    Chuanbao Zhang
    Zhaoshi Bao
    Yanwei Liu
    Anhua Wu
    [J]. Journal of Neuro-Oncology, 2015, 122 : 303 - 312
  • [49] HDAC4, a prognostic and chromosomal instability marker, refines the predictive value of MGMT promoter methylation
    Cheng, Wen
    Li, Mingyang
    Cai, Jinquan
    Wang, Kuanyu
    Zhang, Chuanbao
    Bao, Zhaoshi
    Liu, Yanwei
    Wu, Anhua
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2015, 122 (02) : 303 - 312
  • [50] PROGNOSTIC OR PREDICTIVE VALUE OF MGMT PROMOTER METHYLATION IN MALIGNANT GLIOMAS DEPENDS ON IDH1 MUTATIONS
    Wick, W.
    Meisner, C.
    Hentschel, B.
    Platten, M.
    Sabel, M.
    Koeppen, S.
    Ketter, R.
    Simon, M.
    Reifenberger, G.
    Weller, M.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 7 - 7
12345